Translate Bio
Developing mRNA medicines to restore protein function.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD4.4b (Public information from Aug 2021)
Share price
$37.36
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $2.7m | Early VC | |
$20.7m | Series A | ||
$63.8m | Series B | ||
N/A | $51.0m | Series C | |
N/A | $122m Valuation: $582m | IPO | |
$3.2b Valuation: $3.2b | Acquisition | ||
Total Funding | CAD188m |